Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications

Journal of Proteomics

Volumn 74, Issue 12, 2011, Pages 2691-2702

  Song, Byoung Joon ^a   Abdelmegeed, Mohamed A ^a   Yoo, Seong Ho ^a,b   Kim, Bong Jo ^a,c   Jo, Sangmee A ^d   Jo, Inho ^e   Moon, Kwan Hoon ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b Seoul National University College of Medicine   (South Korea)

^c Korea National Institute of Health   (South Korea)

^d Dankook University   (South Korea)

^e Ewha Womans University School of Medicine   (South Korea)

Author keywords

Aldehyde dehydrogenases; Cellular defense; Disease states; Drug toxicity; Post translational modifications; Translational research

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACROLEIN; ALCOHOL; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; AMINO ACID; ARGININE; CARBON TETRACHLORIDE; CYANAMIDE; CYSTEINE; CYTOCHROME P450 2E1; DAIDZIN; DAUNORUBICIN; DISULFIRAM; GLYCERYL TRINITRATE; HISTIDINE; ISOENZYME; LYSINE; METHIONINE; PARACETAMOL; PARGYLINE; PHENYLALANINE; PROLINE; PROTEIN KINASE C EPSILON; RESERPINE; THREONINE; TOXIC SUBSTANCE; TRYPTOPHAN; TYROSINE; UNINDEXED DRUG;

ACETYLATION; AMINO ACID SEQUENCE; CARDIOVASCULAR DISEASE; CELL DAMAGE; DRUG EFFICACY; DRUG INHIBITION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; LIPID PEROXIDATION; MEDICAL TECHNOLOGY; MITOCHONDRION; MOLECULE; NITRATION; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; TRANSLATIONAL RESEARCH;

ACETALDEHYDE; ALDEHYDE DEHYDROGENASE; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; ENZYME ACTIVATORS; GENES, DOMINANT; HUMANS; LIPID PEROXIDES; LIVER DISEASES, ALCOHOLIC; MITOCHONDRIAL PROTEINS; MUTATION; MYOCARDIAL INFARCTION; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RISK FACTORS;

EID: 81055158018     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.05.013     Document Type: Review

References (136)

1. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128.
2. LoPachin R.M., Gavin T., Petersen D.R., Barber D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem Res Toxicol 2009, 22:1499-1508.
3. Chaudhary P., Sharma R., Sharma A., Vatsyayan R., Yadav S., Singhal S.S., et al. Mechanisms of 4-hydroxy-2-nonenal induced pro- and anti-apoptotic signaling. Biochemistry 2010, 49:6263-6275.
4. Raza H., John A. 4-Hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Appl Pharmacol 2006, 216:309-318.
5. Soh Y., Jeong K.S., Lee I.J., Bae M.A., Kim Y.C., Song B.J. Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal induced apoptosis of PC12 cells. Mol Pharmacol 2000, 58:535-541.
6. Siems W., Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003, 24:167-175.
7. Alary J., Gueraud F., Cravedi J.P. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol Aspects Med 2003, 24:177-187.
8. Hartley D.P., Ruth J.A., Petersen D.R. The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. Arch Biochem Biophys 1995, 316:197-205.
9. Sladek N.E. Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J Biochem Mol Toxicol 2003, 17:7-23.
10. Marchitti S.A., Brocker C., Stagos D., Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008, 4:697-720.
11. Black W.J., Stagos D., Marchitti S.A., Nebert D.W., Tipton K.F., Bairoch A., et al. Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature. Pharmacogenet Genomics 2009, 19:893-902.
12. Klyosov A.A., Rashkovetsky L.G., Tahir M.K., Keung W.M. Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism. Biochemistry 1996, 35:4445-4456.
13. Svanas G.W., Weiner H. Aldehyde dehydrogenase activity as the rate-limiting factor for acetaldehyde metabolism in rat liver. Arch Biochem Biophys 1985, 236:36-46.
14. Day C.P., Bashir R., James O.F., Bassendine M.F., Crabb D.W., Thomasson H.R., et al. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 1991, 14:798-801.
15. Chambliss K.L., Caudle D.L., Hinson D.D., Moomaw C.R., Slaughter C.A., Jakobs C., et al. Molecular cloning of the mature NAD(+)-dependent succinic semialdehyde dehydrogenase from rat and human. cDNA isolation, evolutionary homology, and tissue expression. J Biol Chem 1995, 270:461-467.
16. Brocker C., Lassen N., Estey T., Pappa A., Cantore M., Orlova V.V., et al. Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress. J Biol Chem 2010, 285:18452-18463.
17. Agarwal D.P., Goedde H.W. Pharmacogenetics of alcohol metabolism and alcoholism. Pharmacogenetics 1992, 2:48-62.
18. Chao Y.C., Liou S.R., Chung Y.Y., Tang H.S., Hsu C.T., Li T.K., et al. Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology 1994, 19:360-366.
19. Higuchi S., Matsushita S., Muramatsu T., Murayama M., Hayashida M. Alcohol and aldehyde dehydrogenase genotypes and drinking behavior in Japanese. Alcohol Clin Exp Res 1996, 20:493-497.
20. Yokoyama A., Muramatsu T., Ohmori T., Yokoyama T., Okuyama K., Takahashi H., et al. Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 1998, 19:1383-1387.
21. Muto M., Hitomi Y., Ohtsu A., Ebihara S., Yoshida S., Esumi H. Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut 2000, 47:256-261.
22. Takagi S., Iwai N., Yamauchi R., Kojima S., Yasuno S., Baba T., et al. Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertens Res 2002, 25:677-681.
23. Jo S.A., Kim E.K., Park M.H., Han C., Park H.Y., Jang Y., et al. A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men. Clin Chim Acta 2007, 382:43-47.
24. Hjelle J.J., Grubbs J.H., Beer D.G., Petersen D.R. Inhibition of rat liver aldehyde dehydrogenase by carbon tetrachloride. J Pharmacol Exp Ther 1981, 219:821-826.
25. Hjelle J.J., Grubbs J.H., Beer D.G., Petersen D.R. Time course of the carbon tetrachloride-induced decrease in mitochondrial aldehyde dehydrogenase activity. Toxicol Appl Pharmacol 1983, 67:159-165.
26. Mitchell D.Y., Petersen D.R. Inhibition of rat liver aldehyde dehydrogenases by acrolein. Drug Metab Dispos 1988, 16:37-42.
27. Banfi P., Lanzi C., Falvella F.S., Gariboldi M., Gambetta R.A., Dragani T.A. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines. Mol Pharmacol 1994, 46:896-900.
28. Landin J.S., Cohen S.D., Khairallah E.A. Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase. Toxicol Appl Pharmacol 1996, 141:299-307.
29. Lipsky J.J., Shen M.L., Naylor S. Overview-in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites. Chem Biol Interact 2001, 130-2:81-91.
30. Suh S.K., Hood B.L., Kim B.J., Conrads T.P., Veenstra T.D., Song B.J. Identification of oxidized mitochondrial proteins in alcohol-exposed human hepatoma cells and mouse liver. Proteomics 2004, 4:3401-3412.
31. Moon K.H., Kim B.J., Song B.J. Inhibition of mitochondrial aldehyde dehydrogenase by nitric oxide-mediated S-nitrosylation. FEBS Lett 2005, 579:6115-6120.
32. Moon K.H., Hood B.L., Kim B.J., Hardwick J.P., Conrads T.P., Veenstra T.D., et al. Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 2006, 44:1218-1230.
33. Kim B.J., Hood B.L., Aragon R.A., Hardwick J.P., Conrads T.P., Veenstra T.D., et al. Increased oxidation and degradation of cytosolic proteins in alcohol-exposed mouse liver and hepatoma cells. Proteomics 2006, 6:1250-1260.
34. Moon K.H., Abdelmegeed M.A., Song B.J. Inactivation of cytosolic aldehyde dehydrogenase via S-nitrosylation in ethanol-exposed rat liver. FEBS Lett 2007, 581:3967-3972.
35. Song B.J., Moon K.H., Olsson N., Salem N. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J Hepatol 2008, 49:262-273.
36. Moon K.H., Upreti V.V., Yu L.R., Lee I.J., Ye X., Eddington N.D., et al. Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics 2008, 8:3906-3918.
37. Moon K.H., Hood B.L., Mukhopadhyay P., Rajesh M., Abdelmegeed M.A., Kwon Y.I., et al. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008, 135:1344-1357.
38. Upreti V.V., Eddington N.D., Moon K.H., Song B.J., Lee I.J. Drug interaction between ethanol and 3,4-methylenedioxy-methamphetamine ("ecstasy"). Toxicol Lett 2009, 188:167-172.
39. Moon K.H., Lee Y.M., Song B.J. Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation. Free Radic Biol Med 2010, 48:391-398.
40. Moon K.H., Kim B.J., Wan J., Lee Y.M., Abdelmegeed M.A., Song B.J. Reversible inactivation of mitochondrial aldehyde dehydrogenase by translational modifications in hepatoma cells and alcohol-fed rat livers. Enzymology and molecular biology of carbonyl metabolism 2007, vol. 13:22-32. Purdue University Press, West Lafayette, Indiana, USA. H. Weiner, B.V. Plapp, R. Lindahl, E. Maser (Eds.).
41. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997, 272:20313-20316.
42. Petersen D.R., Doorn J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004, 37:937-945.
43. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87:315-424.
44. DeMaster E.G., Quast B.J., Redfern B., Nagasawa H.T. Reaction of nitric oxide with the free sulfhydryl group of human serum albumin yields a sulfenic acid and nitrous oxide. Biochemistry 1995, 34:11494-11499.
45. DeMaster E.G., Redfern B., Quast B.J., Dahlseid T., Nagasawa H.T. Mechanism for the inhibition of aldehyde dehydrogenase by nitric oxide. Alcohol 1997, 14:181-189.
46. Cumming R.C., Andon N.L., Haynes P.A., Park M., Fischer W.H., Schubert D. Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem 2004, 279:21749-21758.
47. Daiber A., Oelze M., Coldewey M., Bachschmid M., Wenzel P., Sydow K., et al. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 2004, 66:1372-1382.
48. Woo H.A., Jeong W., Chang T.S., Park K.J., Park S.J., Yang J.S., et al. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem 2005, 280:3125-3128.
49. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991, 266:4244-4250.
50. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005, 6:150-166.
51. McDonald L.J., Moss J. Nitric oxide-independent, thiol-associated ADP ribosylation inactivates aldehyde dehydrogenase. J Biol Chem 1993, 268:17878-17882.
52. Wenzel P., Hink U., Oelze M., Schuppan S., Schaeuble K., Schildknecht S., et al. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem 2007, 282:792-799.
53. Hochgräfe F., Mostertz J., Pöther D.C., Becher D., Helmann J.D., Hecker M. S-cysteinylation is a general mechanism for thiol protection of Bacillus subtilis proteins after oxidative stress. J Biol Chem 2007, 282:25981-25985.
54. Frizzell N., Rajesh M., Jepson M.J., Nagai R., Carson J.A., Thorpe S.R., et al. Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin. J Biol Chem 2009, 284:25772-25781.
55. Farres J., Wang T.T., Cunningham S.J., Weiner H. Investigation of the active site cysteine residue of rat liver mitochondrial aldehyde dehydrogenase by site-directed mutagenesis. Biochemistry 1995, 34:2592-2598.
56. Palmer K.R., Jenkins W.J. Aldehyde dehydrogenase in alcoholic subjects. Hepatology 1985, 5:260-263.
57. Agarwal D.P., Harada S., Goedde H.W., Schrappe O. Cytosolic aldehyde dehydrogenase and alcoholism. Lancet 1983, 1(8314-5):68.
58. Koop D.R. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 1992, 6:724-730.
59. Song B.J., Koop D.R., Ingelman-Sundberg M., Nanji A., Cederbaum A.I. Ethanol-inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance: 1996 update. Alcohol Clin Exp Res 1996, 20(Suppl):138A-146A.
60. Caro A.A., Cederbaum A.I. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 2004, 44:27-42.
61. Purohit V., Gao B., Song B.J. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009, 33:191-205.
62. Song B.J., Suh S.K., Moon K.H. A simple method to systematically study oxidatively modified proteins in biological samples and its applications. Methods Enzymol 2010, 473:251-264.
63. Song B.J., Moon K.H., Upreti V.V., Eddington N.D., Lee I.J. Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage. Curr Pharm Biotechnol 2010, 11:434-443.
64. Sun J., Steenbergen C., Murphy E. S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal 2006, 8:1693-1705.
65. Sun J., Murphy E. Protein S-nitrosylation and cardioprotection. Circ Res 2010, 106:285-296.
66. Guengerich F.P., Kim D.H., Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991, 4:168-179.
67. 4, its substrate. Biochem Biophys Res Commun 1991, 179:449-454.
68. Lieber C.S. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 2004, 36:511-529.
69. Abdelmegeed M.A., Moon K.H., Chen C., Gonzalez F.J., Song B.J. Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochem Pharmacol 2010, 79:57-66.
70. Jeong K.S., Soh Y., Jeng J., Felder M.R., Hardwick J.P., Song B.J. Cytochrome P450 2E1 (CYP2E1)-dependent production of a 37-kDa acetaldehyde-protein adduct in the rat liver. Arch Biochem Biophys 2000, 384:81-87.
71. 2-terminal protein kinase-related cell death pathway. Mol Pharmacol 2001, 60:847-856.
72. Recknagel R.O., Glende E.A., Dolak J.A., Waller R.L. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 1989, 43:139-154.
73. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34:9-19.
74. Minko I.G., Kozekov I.D., Harris T.M., Rizzo C.J., Lloyd R.S., Stone M.P. Chemistry and biology of DNA containing 1, N(2)-deoxyguanosine adducts of the alpha, beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem Res Toxicol 2009, 22:759-778.
75. Lee Y.J., Aroor A.R., Shukla S.D. Temporal activation of p42/44 mitogen-activated protein kinase and c-Jun N-terminal kinase by acetaldehyde in rat hepatocytes and its loss after chronic ethanol exposure. J Pharmacol Exp Ther 2002, 301:908-914.
76. Yoo S.H., Park O., Henderson L.E., Abdelmegeed M.A., Moon K.H., Song B.J. Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress. Toxicol Lett 2011, 202:23-29.
77. Mendelson K.G., Contois L.R., Tevosian S.G., Davis R.J., Paulson K.E. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 1996, 93:12908-12913.
78. Bae M.A., Song B.J. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells. Mol Pharmacol 2003, 63:401-408.
79. Kim B.J., Ryu S.W., Song B.J. JNK- and p38 kinase mediated phosphorylation of Bax leads to its activation, mitochondrial translocation and apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006, 281:21256-21265.
80. Kharbanda S., Saxena S., Yoshida K., Pandey P., Kaneki M., Wang Q., et al. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J Biol Chem 2000, 275:322-327.
81. Hanawa N., Shinohara M., Saberi B., Gaarde W.A., Han D., Kaplowitz N. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 2008, 283:13565-13577.
82. Chen C.-H., Gray M.O., Mochly-Rosen D. Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci USA 1999, 96:12784-12789.
83. Churchill E.N., Disatnik M.H., Mochly-Rosen D. Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol 2009, 46:278-284.
84. Chen C.-H., Budas G.R., Churchill E.N., Disatnik M.-H., Hurley T.D., Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008, 321:1493-1495.
85. Budas G.R., Disatnik M.H., Chen C.H., Mochly-Rosen D. Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCepsilon) knockout mice. J Mol Cell Cardiol 2010, 48:757-764.
86. Perez-Miller S., Younus H., Vanam R., Chen C.H., Mochly-Rosen D., Hurley T.D. Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat Struct Mol Biol 2010, 17:159-164.
87. Lagranha C.J., Deschamps A., Aponte A., Steenbergen C., Murphy E. Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res 2010, 106:1681-1691.
88. Wong R., Aponte A.M., Steenbergen C., Murphy E. Cardioprotection leads to novel changes in the mitochondrial proteome. Am J Physiol Heart Circ Physiol 2010, 298:H75-H91.
89. Sydow K., Daiber A., Oelze M., Chen Z., August M., Wendt M., et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 2004, 113:482-489.
90. Chen Z., Foster M.W., Zhang J., Mao L., Rockman H.A., Kawamoto T., et al. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci USA 2005, 102:12159-12164.
91. Daiber A., Wenzel P., Oelze M., Schuhmacher S., Jansen T., Münzel T. Mitochondrial aldehyde dehydrogenase (ALDH-2)-maker of and marker for nitrate tolerance in response to nitroglycerin treatment. Chem Biol Interact 2009, 178:40-47.
92. Beretta M., Sottler A., Schmidt K., Mayer B., Gorren A.C. Partially irreversible inactivation of mitochondrial aldehyde dehydrogenase by nitroglycerin. J Biol Chem 2008, 283:30735-30744.
93. Oelze M., Knorr M., Schell R., Kamuf J., Pautz A., Art J., et al. Regulation of human mitochondrial aldehyde dehydrogenase (ALDH-2) activity by electrophiles in vitro. J Biol Chem 2011, 286:8893-8900.
94. Tyther R., Ahmeda A., Johns E., Sheehan D. Proteomic identification of tyrosine nitration targets in kidney of spontaneously hypertensive rats. Proteomics 2007, 7:4555-4564.
95. Lu Z., Scott I., Webster B.R., Sack M.N. The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology. Circ Res 2009, 105:830-841.
96. Fu M., Wang C., Zhang X., Pestell R.G. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 2004, 68:1199-1208.
97. Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464(7285):121-125.
98. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006, 23:607-618.
99. Shepard B.D., Tuma D.J., Tuma P.L. Chronic ethanol consumption induces global hepatic protein hyperacetylation. Alcohol Clin Exp Res 2010, 34:280-291.
100. Kendrick A.A., Choudhury M., Rahman S.M., McCurdy C.E., Friederich M., Vanhove J.L., et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J 2011, 433:505-514.
101. Sheikh S., Ni L., Hurley T.D., Weiner H. The potential roles of the conserved amino acids in human liver mitochondrial aldehyde dehydrogenase. J Biol Chem 1997, 272:18817-18822.
102. You M., Liang X., Ajmo J.M., Ness G.C. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 2008, 294:G892-G898.
103. Lieber C.S., Leo M.A., Wang X., Decarli L.M. Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1alpha in rats. Biochem Biophys Res Commun 2008, 370:44-48.
104. Picklo M.J. Ethanol intoxication increases hepatic N-lysyl protein acetylation. Biochem Biophys Res Commun 2008, 376:615-619.
105. Shulga N., Pastorino J.G. Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3. J Cell Sci 2010, 123:4117-4127.
106. Lieber C.S., Leo M.A., Wang X., Decarli L.M. Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function. Biochem Biophys Res Commun 2008, 373:246-252.
107. Svanas G.W., Weiner H. Enzymative requirement for cyanamide inactivation of rat liver aldehyde dehydrogenase. Biochem Pharmacol 1985, 34:1197-1204.
108. Keung W.M., Klyosov A.A., Vallee B.L. Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters. Proc Natl Acad Sci USA 1997, 94:1675-1679.
109. M aldehyde dehydrogenase activity in H4-II-E-C3 rat hepatoma cells. Alcohol 2003, 31:19-24.
110. Lebsack M.E., Petersen D.R., Collins A.C., Anderson A.D. Preferential inhibition of the low Km aldehyde dehydrogenase activity by pargyline. Biochem Pharmacol 1977, 26:1151-1154.
111. Doorn J.A., Hurley T.D., Petersen D.R. Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal. Chem Res Toxicol 2006, 19:102-110.
112. Yoshida A., Huang I.Y., Ikawa M. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc Natl Acad Sci USA 1984, 81:258-261.
113. Brooks P.J., Enoch M.A., Goldman D., Li T.K., Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med 2009, 6:e50.
114. Wang R.S., Nakajima T., Kawamoto T., Honma T. Effects of aldehyde dehydrogenase-2 genetic polymorphisms on metabolism of structurally different aldehydes in human liver. Drug Metab Dispos 2002, 30:69-73.
115. Isse T., Matsuno K., Oyama T., Kitagawa K., Kawamoto T. Aldehyde dehydrogenase 2 gene targeting mouse lacking enzyme activity shows high acetaldehyde level in blood, brain, and liver after ethanol gavages. Alcohol Clin Exp Res 2005, 29:1959-1964.
116. Quintanilla M.E., Tampier L., Sapag A., Israel Y. Polymorphisms in the mitochondrial aldehyde dehydrogenase gene (Aldh2) determine peak blood acetaldehyde levels and voluntary ethanol consumption in rats. Pharmacogenet Genomics 2005, 15:427-431.
117. Chen J.J., Yu B.P. Detoxification of reactive aldehydes in mitochondria: effects of age and dietary restriction. Aging (Milano) 1996, 8:334-340.
118. Watanabe A., Hobara N., Nakatsukasa H., Shiota T., Kobayashi M., Nagashima H. Impaired acetaldehyde metabolism in partially hepatectomized rats. Res Exp Med 1985, 185:13-20.
119. Park K.S., Cho S.Y., Kim H., Paik Y.K. Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int J Cancer 2002, 97:261-265.
120. Kim J., Kim S.H., Lee S.U., Ha G.H., Kang D.G., Ha N.Y., et al. Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 2002, 23:4142-4156.
121. Shibuya A., Takeuchi A., Shibata H., Saigenji K., Yoshida A. Immunohistochemical study of hepatocellular carcinoma-specific aldehyde dehydrogenase. Alcohol Alcohol Suppl 1994, 29:119-123.
122. Oshita F., Morita A., Ito H., Kameda Y., Tsuchiya E., Asai S., et al. Proteomic screening of completely resected tumors in relation to survival in patients with stage I non-small cell lung cancer. Oncol Rep 2010, 24:637-645.
123. Zakhari S., Li T.K. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 2007, 46:2032-2039.
124. Venkatraman A., Landar A., Davis A.J., Chamlee L., Sanderson T., Kim H., et al. Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. J Biol Chem 2004, 279:22092-22101.
125. McClain C.J., Kromhout J.P., Peterson F.J., Holtzman J.L. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 1980, 244:251-253.
126. Seeff L.B., Cuccherini B.A., Zimmerman H.J., Adler E., Benjamin S.B. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 1986, 104:399-404.
127. Szabo G., Wands J.R., Eken A., Osna N.A., Weinman S.A., Machida K., et al. Alcohol and hepatitis C virus-interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res 2010, 34:1675-1686.
128. Hassan M.M., Hwang L.Y., Hatten C.J., Swaim M., Li D., Abbruzzese J.L., et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36:1206-1213.
129. Diehl A.M. Obesity and alcoholic liver disease. Alcohol 2004, 34:81-87.
130. Carmiel-Haggai M., Cederbaum A.I., Nieto N. Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 2003, 125:1818-1833.
131. Reid L.W., Elifson K.W., Sterk C.E. Ecstasy and gateway drugs: initiating the use of ecstasy and other drugs. Ann Epidemiol 2007, 17:74-80.
132. Pontes H., Duarte J.A., de Pinho P.G., Soares M.E., Fernandes E., Dinis-Oliveira R.J., et al. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice. Toxicology 2008, 252:64-71.
133. Karahanian E., Ocaranza P., Israel Y. Aldehyde dehydrogenase (ALDH2) activity in hepatoma cells is reduced by an adenoviral vector coding for an ALDH2 antisense mRNA. Alcohol Clin Exp Res 2005, 29:1384-1389.
134. Cortínez G., Sapag A., Israel Y. RNA interference against aldehyde dehydrogenase-2: development of tools for alcohol research. Alcohol 2009, 43:97-104.
135. Li Y., Zhang D., Jin W., Shao C., Yan P., Xu C., et al. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J Clin Invest 2006, 116:506-511.
136. Schuhmacher S., Schulz E., Oelze M., König A., Roegler C., Lange K., et al. A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena. Br J Pharmacol 2009, 158:510-520.